# US Gastric Bypass Market > US Gastric Bypass Market Research Report By Type (Endoscopic Sleeve Gastroplasty, Intragastric Balloon), By Indication (Gastroesophageal Reflux Disease, Heart Disease, Type 2 Diabetes) and By End User (Hospitals, Surgical Centers) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.8% - **2024:** $ 0.65 Million - **2025:** $ 0.69 Million - **2035:** $ 1.21 Million - **Key Players:** Johnson & Johnson (US), Medtronic (US), Boston Scientific (US), Stryker (US), B. Braun Melsungen AG (DE), Ethicon (US), Intuitive Surgical (US), Conmed Corporation (US) **Report ID:** MRFR/MED/15158-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-gastric-bypass-market-16686 --- ## Market Summary ## **US Gastric Bypass Market Overview** As per MRFR analysis, the US Gastric Bypass Market Size was estimated at 212.34 (USD Million) in 2023. The US Gastric Bypass Market Industry is expected to grow from 250 (USD Million) in 2024 to 550 (USD Million) by 2035.The US Gastric Bypass Market CAGR (growth rate) is expected to be around 7.431% during the forecast period (2025 - 2035). ### **Key US Gastric Bypass Market Trends Highlighted** The US Gastric Bypass Market is experiencing several significant trends shaped by various factors. A primary market driver is the rising prevalence of obesity among the American population, which has led to increased demand for bariatric surgeries as an effective treatment option. Government health initiatives aimed at reducing obesity-related health problems have also promoted awareness about the benefits of surgical interventions. Additionally, technological advancements in surgical procedures, including minimally invasive techniques, have gained traction, making gastric bypass surgeries safer and more effective; this has resonated well with patients and healthcare providers alike. There are notable opportunities to be explored within the market. Increased insurance coverage for bariatric procedures, spurred by changes in policy related to obesity management, allows more individuals to consider gastric bypass as a viable option. Furthermore, the development of innovative preoperative and postoperative care programs offers potential for improving patient outcomes, thereby appealing to both healthcare providers and patients looking for comprehensive treatment solutions. In recent times, trends in the US include a shift towards more personalized treatment plans that cater to the specific needs and health status of patients, reflecting broader movements in healthcare towards tailored treatments. The integration of digital health tools, such as telemedicine and mobile health applications, is enhancing patient engagement and support throughout the weight-loss journey. This focus on holistic approaches in the US Gastric Bypass Market ensures that patients receive tailored care, improving long-term success rates and overall satisfaction with surgical outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Gastric Bypass Market Drivers** ### **Rising Obesity Rates in the United States** The United States has seen a dramatic increase in obesity rates over the past few decades, which significantly drives the US [Gastric Bypass Market](../../../reports/gastric-bypass-market-5321) Industry. According to the Centers for Disease Control and Prevention (CDC), the prevalence of obesity among US adults was 42.4% in 2017-2018, an increase from 30.5% in 1999-2000. This upward trend poses serious health risks, necessitating effective weight loss solutions. The American Society for Metabolic and Bariatric Surgery (ASMBS) indicates that patients suffering from morbid obesity and related comorbidities often turn to surgical interventions, such as gastric bypass, as a more effective and long-term solution compared to lifestyle changes alone. With the escalating obesity epidemic, more individuals are seeking bariatric surgeries to improve their health, thereby fueling growth in the US Gastric Bypass Market. Furthermore, with over 13 million adults estimated to be eligible for bariatric surgery, the market size is projected to grow significantly as healthcare providers increasingly recommend surgical interventions. ### **Increased Awareness and Acceptance of Bariatric Surgery** In recent years, there has been a significant increase in awareness and acceptance of bariatric surgery options, including gastric bypass, among US populations. Educational initiatives from organizations like the American Bariatric Surgical Center and the National Institute of Health highlight the benefits and outcomes associated with these procedures, leading to greater public trust. A recent survey by the ASMBS found that only 30% of severely obese individuals were aware of bariatric surgery as a treatment but this figure is steadily on the rise. Improved awareness is essential as the population becomes more informed about the potential risks and benefits of surgery, thus driving the US Gastric Bypass Market Industry. ### **Advancements in Medical Technology and Surgical Techniques** Medical technology has witnessed remarkable advancements, particularly in the field of minimally invasive surgical techniques used in gastric bypass procedures. The introduction of new surgical tools and robotic-assisted surgery technologies, endorsed by organizations like the American College of Surgeons, have led to improved patient outcomes, shorter recovery times, and reduced hospital stays. According to a study published by the Journal of American Medical Association, minimally invasive gastric bypass procedures showcase a 50% reduction in complication rates compared to traditional surgical methods. These advancements are critical in attracting more patients towards surgery as they seek safer and more effective treatment options, thus propelling the growth of the US Gastric Bypass Market. ### **Government Initiatives to Address Healthcare Costs** US government initiatives aimed at decreasing healthcare costs related to obesity and associated diseases also play a crucial role in driving the US Gastric Bypass Market Industry. The Affordable Care Act expanded coverage for bariatric surgery, allowing more individuals to access these life-changing procedures. A report from the Congressional Budget Office suggests that every dollar spent on bariatric surgery could save approximately $3 in future healthcare costs stemming from obesity-related diseases. As more healthcare plans include bariatric surgery coverage, the rising number of insured patients seeking gastric bypass procedures is expected to significantly bolster market growth. ## **US Gastric Bypass Market Segment Insights** ### **Gastric Bypass Market Type Insights** The US Gastric Bypass Market, categorized by Type, showcases significant segments that contribute to the overall landscape of bariatric surgery. Among these, Endoscopic Sleeve Gastroplasty and Intragastric Balloon have emerged as pivotal procedures. Endoscopic Sleeve Gastroplasty, a minimally invasive technique, has gained traction owing to its effectiveness and lower complication rates, appealing to patients seeking an alternative to traditional surgical methods. This procedure essentially reshapes the stomach using endoscopic suturing without the need for surgical incisions, thus minimizing recovery time and allowing patients to return to daily activities faster. Meanwhile, the Intragastric Balloon procedure provides a temporary aid for weight loss by placing a soft balloon in the stomach, creating a feeling of fullness, which supports patients in achieving their weight loss goals without permanent alterations to their anatomy. These segments collectively contribute to the burgeoning interest in weight loss solutions across the US, echoing the increasing prevalence of obesity within the population. According to recent statistics, nearly 42% of US adults are classified as obese, amplifying the demand for effective weight management solutions, including these procedural types. The growth drivers for these segments also align with rising healthcare awareness and a greater focus on preventing obesity-related complications, such as diabetes and hypertension. Furthermore, government initiatives to promote healthy living and weight management among citizens continue to bolster the relevance of these interventions. However, challenges remain, such as patient education regarding procedure options and potential risks associated with each type. Nevertheless, both Endoscopic Sleeve Gastroplasty and Intragastric Balloon represent growing opportunities within the market, as advancements in technology and increasing acceptance of less invasive techniques attract a wider patient demographic. In summary, the Type segmentation within the US Gastric Bypass Market illustrates a dynamic interplay between innovative procedures and evolving patient needs, paving the way for future developments in the realm of bariatric surgery.  Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Gastric Bypass Market Indication Insights** The US Gastric Bypass Market, focusing on the Indication segment, is shaped by the rising prevalence of various health conditions such as Gastroesophageal Reflux Disease, Heart Disease, and Type 2 Diabetes. Gastric bypass surgery is often performed on patients suffering from these serious health issues as an effective solution for weight management and improving overall health outcomes. For instance, Gastroesophageal Reflux Disease, characterized by persistent acid reflux, affects millions of Americans, and studies suggest that bariatric surgery significantly alleviates symptoms in such patients, offering a substantial quality-of-life improvement. Heart Disease remains a leading cause of mortality, and weight loss via gastric bypass can lead to lower risks of heart issues by reducing associated comorbidities. Type 2 Diabetes affects a significant portion of the American population, with numerous studies indicating that gastric bypass contributes to long-term remission in diabetic patients. These health conditions underscore the importance of the Indication segment, making it a key driver of demand in the US Gastric Bypass Market, ultimately enabling patients to achieve better health and reduce the burden on healthcare systems. The ongoing advancements in surgical techniques and the growing awareness of obesity as a major health crisis add to the opportunities for growth within this sector. ### **Gastric Bypass Market End User Insights** The US Gastric Bypass Market segmentation by End User is significant, particularly highlighting the roles of Hospitals and Surgical Centers. Hospitals serve as the primary point for comprehensive patient care, offering advanced medical technologies and specialized personnel for managing complex cases involving gastric bypass procedures. Their integration into the healthcare system facilitates a multidisciplinary approach, optimizing patient outcomes and satisfaction. Surgical Centers, on the other hand, focus on efficient delivery of outpatient surgical services. They provide convenience and cost-effectiveness, often leading to quicker recovery times for patients post-operation. As both End Users adapt to evolving healthcare demands and technological advancements, factors like rising obesity rates in the US bolster their importance. The flexibility of Surgical Centers allows them to accommodate a growing number of procedures, while Hospitals uphold quality standards and ensure extensive follow-up care. Together, they create a synergistic landscape that supports the US Gastric Bypass Market, driven by the need for accessible and effective treatment options for obesity-related health issues. Trends indicate a steady upward trajectory in procedures performed, reflecting the increasing acceptance and demand for gastric bypass surgery in the population. ## **US Gastric Bypass Market Key Players and Competitive Insights** The US Gastric Bypass Market is characterized by a dynamic landscape driven by advancements in surgical techniques and emerging technologies aimed at enhancing patient outcomes. This market comprises various stakeholders, including medical device manufacturers, healthcare providers, and surgical centers. The competition within this sector is intensifying as players strive to innovate and deliver effective treatments for obesity, which has reached epidemic proportions in the United States. The entry of new technologies and a growing emphasis on minimally invasive procedures are reshaping the market dynamics, with companies investing in research and development to capture a larger market share. As a result, the competitive environment is marked by partnerships, collaborations, and strategic alliances aimed at expanding product offerings and increasing accessibility for patients seeking gastric bypass procedures. Hologic holds a notable position in the US Gastric Bypass Market, primarily recognized for its advanced medical technology solutions that cater to women's health. With a strong focus on innovative surgical instruments and imaging technologies, Hologic has managed to gain a competitive edge. The company’s strengths lie in its robust product portfolio that enhances surgical precision and safety during gastric bypass procedures. Hologic's commitment to clinical research and development allows it to refine its offerings continually, promoting better outcomes for patients. Through strategic engagement with healthcare professionals and institutions, Hologic has bolstered its presence in the US market, thus establishing itself as a trusted brand among surgeons and patients alike. Bariatric Solutions is another important player in the US Gastric Bypass Market, specializing in the provision of treatments and services related to obesity management. The company focuses on delivering innovative bariatric equipment and surgical solutions designed to support both healthcare providers and patients throughout the weight loss journey. Bariatric Solutions prides itself on its comprehensive service offerings that include not only surgical devices but also patient education and support systems, which are critical for long-term success. The company's strong market presence is reflected in its collaborations with various healthcare institutions, enhancing accessibility to their products. Additionally, Bariatric Solutions has pursued strategic mergers and acquisitions, enabling it to expand its portfolio and increase its competitiveness in the US market, positioning itself as a reliable partner in addressing the obesity crisis in the region. ### **Key Companies in the US Gastric Bypass Market Include** ## **US Gastric Bypass Market Industry Developments** The US Gastric Bypass Market has seen significant developments recently, with advances in technology and increased patient accessibility driving growth. Companies like Hologic and Medtronic are focusing on innovative surgical instruments and techniques that enhance patient outcomes. In June 2023, Johnson and Johnson completed its acquisition of a surgical robotics firm, expanding its expertise in minimally invasive procedures, further pushing the capabilities in this market. In July 2023, Boston Scientific showcased new devices aimed at improving long-term weight loss results, highlighting the competitive landscape. Additionally, Acelity has been investing in R&D to improve wound management post-surgery, which directly impacts recovery times and patient satisfaction. Market valuation for the Gastric Bypass sector has increased significantly, with a notable uptick in demand for personalized treatment options. In the previous years, particularly in 2021 and 2022, there was notable growth driven by a nationwide increase in obesity rates, pushing more patients toward surgical options. With continual advancements in surgical techniques and equipment, the market is poised for sustained expansion, emphasizing the importance of adaptive strategies by key players like Ethicon, Stryker, and Intuitive Surgical. ## **US Gastric Bypass Market Segmentation Insights** ### **Gastric Bypass Market Type Outlook** ### **Gastric Bypass Market Indication Outlook** ### **Gastric Bypass Market End User Outlook** ## Market Drivers ### Rising Obesity Rates The increasing prevalence of obesity in the US is a primary driver for the gastric bypass market. According to the CDC, approximately 42.4% of adults were classified as obese in 2017-2018, a figure that has likely risen. This alarming trend has led to a greater demand for surgical interventions, including gastric bypass procedures. As obesity is linked to various comorbidities such as diabetes, hypertension, and cardiovascular diseases, the urgency for effective weight-loss solutions has intensified. The gastric bypass market is responding to this need by expanding its offerings and improving surgical outcomes. Furthermore, the economic burden of obesity, estimated at $147 billion annually, underscores the necessity for effective treatments, thereby propelling the market forward. ### Evolving Patient Demographics The evolving demographics of patients seeking gastric bypass surgery are influencing the market dynamics. An increasing number of younger individuals, including adolescents, are being diagnosed with obesity, prompting a shift in the target demographic for the gastric bypass market. This trend indicates a need for tailored surgical solutions that address the unique challenges faced by younger patients. Additionally, the growing diversity in the patient population necessitates culturally competent care and consideration of varying health beliefs. The gastric bypass market must adapt to these changing demographics by offering personalized treatment plans and support systems. As more individuals from diverse backgrounds seek surgical options, the market is likely to expand, reflecting the need for inclusive healthcare solutions. ### Advancements in Surgical Technology Technological innovations in surgical techniques are significantly influencing the gastric bypass market. Minimally invasive procedures, such as laparoscopic gastric bypass, have gained traction due to their reduced recovery times and lower complication rates. The introduction of robotic-assisted surgeries further enhances precision and patient outcomes. As these technologies become more accessible, the gastric bypass market is likely to experience increased adoption rates among healthcare providers. Moreover, the integration of advanced imaging techniques and surgical simulations is expected to improve preoperative planning and postoperative care. This evolution in surgical technology not only enhances patient safety but also contributes to the overall growth of the gastric bypass market, as more patients seek these advanced treatment options. ### Growing Demand for Weight Loss Solutions The rising demand for effective weight loss solutions is a crucial driver for the gastric bypass market. With a significant portion of the population struggling with obesity, many individuals are turning to surgical options as a viable alternative to traditional weight loss methods. The gastric bypass market is witnessing an increase in patient inquiries and consultations, reflecting a shift in attitudes towards surgical interventions. Additionally, the success rates associated with gastric bypass procedures, which can lead to substantial weight loss and improvement in obesity-related conditions, are encouraging more patients to consider this option. As awareness of the benefits of surgical weight loss continues to grow, the market is poised for further expansion. ### Increased Focus on Preventive Healthcare The growing emphasis on preventive healthcare is shaping the landscape of the gastric bypass market. As healthcare providers and policymakers prioritize preventive measures, there is a heightened awareness of the long-term health implications of obesity. This shift is prompting more individuals to seek surgical interventions as a proactive approach to managing their weight and associated health risks. The gastric bypass market is likely to benefit from this trend, as patients increasingly view surgery as a means to prevent serious health issues rather than merely a cosmetic procedure. Furthermore, the integration of weight management programs and lifestyle modifications alongside surgical options is expected to enhance patient outcomes and satisfaction, thereby driving market growth. ## Future Outlook The [Gastric Bypass Market](https://www.marketresearchfuture.com/reports/gastric-bypass-market-5321) is projected to grow at a 5.8% CAGR from 2025 to 2035, driven by increasing obesity rates, technological advancements, and rising healthcare expenditure. **New opportunities:** - Expansion of telehealth services for pre- and post-operative care - Development of minimally invasive surgical techniques - Partnerships with insurance providers for better coverage options By 2035, the gastric bypass market is expected to achieve robust growth and enhanced service offerings. ## Segment Insights ### By Type: Endoscopic Sleeve Gastroplasty (Largest) vs. Intragastric Balloon (Fastest-Growing) The US gastric bypass market shows a significant distribution of market share between Endoscopic Sleeve Gastroplasty and Intragastric Balloon. Currently, Endoscopic Sleeve Gastroplasty dominates the market due to its minimally invasive nature and effectiveness in weight loss, capturing the largest share. In contrast, the Intragastric Balloon is gaining traction, appealing to patients looking for non-surgical alternatives, thus carving out a considerable market presence. Looking ahead, the growth trends indicate a favorable shift towards non-surgical options, with the Intragastric Balloon emerging as the fastest-growing segment. This growth is driven by increasing awareness of obesity-related health issues and the rising demand for less invasive procedures. Furthermore, technological advancements and marketing efforts have bolstered the accessibility and appeal of these alternatives in the market. Endoscopic Sleeve Gastroplasty (Dominant) vs. Intragastric Balloon (Emerging) Endoscopic Sleeve Gastroplasty is recognized as the dominant player in the US gastric bypass market, offering a highly effective, minimally invasive solution for weight loss. Its innovative approach has led to significant patient satisfaction and lower risk of complications compared to traditional surgical methods. On the other hand, the Intragastric Balloon represents an emerging option, gaining popularity among individuals hesitant to undergo surgery. This segment is characterized by its reversible nature and lower upfront costs, appealing to a broader demographic. As both treatment options continue to evolve, they provide patients with more choices tailored to their health needs and goals. ### By Indication: Obesity (Largest) vs. Type 2 Diabetes (Fastest-Growing) The US gastric bypass market showcases a diverse indication segment, with obesity dominating the market share. This condition accounts for a significant majority of procedures, reflecting the high prevalence of obesity across various demographics. Other indications, such as gastroesophageal reflux disease, heart disease, and high blood pressure, also contribute to the market but to a lesser extent, indicating a concentrated focus on obesity in surgical interventions. Growth trends within this segment are driven by increasing awareness of obesity-related health issues and the effectiveness of gastric bypass surgery in achieving long-term weight loss. Additionally, the rising incident rates of type 2 diabetes have made it an emerging focus area within this segment, propelling demand for gastric bypass as a viable solution for managing insulin resistance and associated metabolic disorders. Obesity: Dominant vs. Type 2 Diabetes: Emerging Obesity represents the dominant indication in the US gastric bypass market, characterized by its significant impact on overall health and increasing rates in various age groups. The overwhelming demand for surgical options stems from the urgent need to address severe obesity and its comorbidities, such as heart disease and type 2 diabetes. In contrast, type 2 diabetes is emerging as a critical indication due to its strong correlation with obesity and the rising trends in diabetes prevalence. As more patients seek surgical intervention for weight loss to combat insulin resistance, the role of gastric bypass in managing diabetes is becoming increasingly recognized, leading to a rise in surgical candidates driven by this condition. ### By End User: Hospitals & Clinics (Largest) vs. Surgical Centers (Fastest-Growing) In the US gastric bypass market, Hospitals & Clinics hold the largest share, primarily due to their comprehensive service offerings and established reputations. These facilities are preferred by patients seeking reliable surgical interventions, leading to a significant portion of the market being captured by them. On the other hand, Surgical Centers, while smaller in market share, have been gaining traction due to their specialized services and the increasing demand for outpatient procedures. The growth trends in this segment are heavily influenced by rising obesity rates and an increasing awareness of the benefits associated with gastric bypass surgery. Surgical Centers are experiencing the fastest growth due to advancements in minimally invasive techniques and enhanced recovery protocols. As healthcare systems evolve, there is a notable shift towards faster and more patient-centric surgical options, driving more patients to these specialized centers for their surgical needs. Hospitals & Clinics (Dominant) vs. Surgical Centers (Emerging) Hospitals & Clinics are the dominant players in the US gastric bypass market, boasting extensive resources, multi-disciplinary care teams, and comprehensive care pathways that attract a vast patient base. Their ability to offer a full spectrum of post-operative care contributes to their market leadership. Conversely, Surgical Centers are emerging as significant competitors by focusing on specific surgical procedures and offering them at lower costs, fostering an environment that prioritizes patient convenience. These centers are adept at utilizing advanced surgical technologies, which enables faster recovery times, making them a preferred choice for many patients. As healthcare shifts towards more efficient models, the role of Surgical Centers is poised to expand, catering to a growing preference for outpatient surgical solutions. ## Competitive Benchmarking The gastric bypass market exhibits a dynamic competitive landscape characterized by rapid innovation and strategic maneuvering among key players. Major companies such as Johnson & Johnson (US), Medtronic (US), and Intuitive Surgical (US) are at the forefront, leveraging their extensive research capabilities and technological advancements to enhance surgical outcomes. Johnson & Johnson (US) focuses on integrating digital health solutions into its surgical platforms, while Medtronic (US) emphasizes the development of minimally invasive techniques. Intuitive Surgical (US) continues to lead in robotic-assisted surgery, which is increasingly becoming a preferred option in gastric bypass procedures. Collectively, these strategies not only enhance patient care but also intensify competition, as companies strive to differentiate themselves through innovation and improved surgical efficacy.Key business tactics within the gastric bypass market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players competing for market share. However, the influence of major companies is substantial, as they set industry standards and drive technological advancements. This competitive environment encourages smaller firms to innovate and adapt, thereby fostering a culture of continuous improvement and responsiveness to market demands. In October Medtronic (US) announced the launch of a new line of advanced surgical instruments designed specifically for gastric bypass procedures. This strategic move is significant as it not only expands Medtronic's product portfolio but also reinforces its commitment to enhancing surgical precision and patient safety. By investing in cutting-edge technology, Medtronic aims to capture a larger share of the market and respond to the growing demand for minimally invasive surgical options. In September Intuitive Surgical (US) unveiled an upgraded version of its robotic surgical system, which includes enhanced imaging capabilities and AI-driven analytics. This development is crucial as it positions Intuitive Surgical to maintain its leadership in robotic-assisted surgeries, particularly in the gastric bypass segment. The integration of AI technology is likely to improve surgical outcomes and streamline the surgical process, thereby attracting more healthcare providers to adopt their systems. In August Johnson & Johnson (US) entered into a strategic partnership with a leading telehealth provider to enhance pre- and post-operative care for gastric bypass patients. This collaboration is indicative of a broader trend towards digital health integration, which aims to improve patient engagement and outcomes. By focusing on comprehensive care solutions, Johnson & Johnson is likely to strengthen its market position and enhance patient satisfaction, which is increasingly becoming a critical factor in healthcare delivery. As of November the competitive trends in the gastric bypass market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a pivotal role in shaping the landscape, as companies seek to combine their strengths to deliver innovative solutions. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in navigating the complexities of the gastric bypass market. ## Recent News & Developments The US Gastric Bypass Market has seen significant developments recently, with advances in technology and increased patient accessibility driving growth. Companies like Hologic and Medtronic are focusing on innovative surgical instruments and techniques that enhance patient outcomes. In June 2023, Johnson and Johnson completed its acquisition of a surgical robotics firm, expanding its expertise in minimally invasive procedures, further pushing the capabilities in this market. In July 2023, Boston Scientific showcased new devices aimed at improving long-term weight loss results, highlighting the competitive landscape. Additionally, Acelity has been investing in R&D to improve wound management post-surgery, which directly impacts recovery times and patient satisfaction. Market valuation for the Gastric Bypass sector has increased significantly, with a notable uptick in demand for personalized treatment options. In the previous years, particularly in 2021 and 2022, there was notable growth driven by a nationwide increase in obesity rates, pushing more patients toward surgical options. With continual advancements in surgical techniques and equipment, the market is poised for sustained expansion, emphasizing the importance of adaptive strategies by key players like Ethicon, Stryker, and Intuitive Surgical. ## Report Scope | MARKET SIZE 2024 | 0.653(USD Million) | | --- | --- | | MARKET SIZE 2025 | 0.691(USD Million) | | MARKET SIZE 2035 | 1.21(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.8% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Johnson & Johnson (US), Medtronic (US), Boston Scientific (US), Stryker (US), B. Braun Melsungen AG (DE), Ethicon (US), Intuitive Surgical (US), Conmed Corporation (US) | | Segments Covered | Type, Indication, End User | | Key Market Opportunities | Emerging minimally invasive techniques enhance patient outcomes in the gastric bypass market. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation and competition in the gastric bypass market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US gastric bypass market in 2024?** A: The market valuation was $0.653 Million in 2024. **Q: What is the projected market valuation for the US gastric bypass market in 2035?** A: The projected valuation for 2035 is $1.21 Million. **Q: What is the expected CAGR for the US gastric bypass market during the forecast period 2025 - 2035?** A: The expected CAGR is 5.8% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the US gastric bypass market?** A: Key players include Johnson & Johnson, Medtronic, Boston Scientific, Stryker, B. Braun Melsungen AG, Ethicon, Intuitive Surgical, and Conmed Corporation. **Q: What are the main types of procedures in the US gastric bypass market?** A: The main types include Endoscopic Sleeve Gastroplasty and Intragastric Balloon. **Q: What was the market size for Endoscopic Sleeve Gastroplasty in 2024?** A: The market size for Endoscopic Sleeve Gastroplasty was $0.4 Million in 2024. **Q: What is the projected market size for Intragastric Balloon by 2035?** A: The projected market size for Intragastric Balloon is $0.46 Million by 2035. **Q: What indications are driving the US gastric bypass market?** A: Indications include Obesity, Gastroesophageal Reflux Disease, Heart Disease, High Blood Pressure, and Type 2 Diabetes. **Q: What was the market size for hospitals and clinics in the US gastric bypass market in 2024?** A: The market size for hospitals and clinics was $0.392 Million in 2024. **Q: What is the expected market size for surgical centers by 2035?** A: The expected market size for surgical centers is $0.392 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-gastric-bypass-market-16686*